In an early stage study recently carried out by the Institute of Kidney Diseases and Research Center (IKDRC), a treatment developed by the IKDRC utilizing Insulin Secreting Cells (ISC), derived from the patient’s own mesenchymal stem cells, shows that the need for insulin doses decreased by an average of 50% when the ISCs were implanted in patients.
This treatment option is an example of what is emerging as the gold standard of stem cell treatments. Recover the patient’s own stem cells, differentiate and culture them in vitro [outside the body] and transplant the cells back into the patient. According to Dr. Vanikar, head of the IKDRC pathology department, "The next level will be to broaden the study and work towards making stem cells which render patients completely drug free".
The best way to prepare yourself and your family for treatments such as this is to save your own [autologous] stem cells. To learn how you can preserve your own valuable stem cells to insure access to emerging personalized regenerative treatments, please visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The future of Regenerative Medicine is now™.